KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin Mar 06, 2024 7:00am EST
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 Feb 21, 2024 7:00am EST
